Pharm Exec: Pharma and Biotech’s 2020 Full-Year View (Young & Partners article – March 2021)

news2021-05-28T16:06:59+00:00March 18th, 2021|Featured, Our Publications|

Examines the key biopharma stock numbers and industry trends from a year that challenged like never before

Medical Device Industry Stock Market Trends

digitalstudios2024-09-18T22:31:39+00:00March 5th, 2021|Issues & Trends, Medical Device Industry - Stock Market Trends|

Chemical Industry Financial Critical Mass

digitalstudios2024-12-09T23:07:16+00:00March 5th, 2021|Chemical Industry - Financial Critical Mass, Issues & Trends|

Pharmaceutical Industry Stock Market Trends

digitalstudios2024-10-14T18:42:22+00:00March 5th, 2021|Issues & Trends, Pharmaceutical Industry - Stock Market Trends|

Biotechnology Industry Stock Market Trends

digitalstudios2024-10-14T18:36:52+00:00March 5th, 2021|Biotechnology Industry - Stock Market Trends, Issues & Trends|

Pharmaceutical Industry Debt and Equity Financing Trends

digitalstudios2024-10-14T18:42:42+00:00March 5th, 2021|Issues & Trends, Pharmaceutical Industry - Debt and Equity Financing Trends|

Pharmaceutical Industry Merger and Acquisition Trends

digitalstudios2024-10-14T18:43:05+00:00March 5th, 2021|Issues & Trends, Pharmaceutical Industry - Merger and Acquisition Trends|

Biotechnology Industry Debt and Equity Financing Trends

digitalstudios2024-10-14T18:37:10+00:00March 5th, 2021|Biotechnology Industry - Debt and Equity Financing Trends, Issues & Trends|

Chemical Industry Debt and Equity Financing Trends

digitalstudios2024-12-09T23:07:22+00:00March 5th, 2021|Chemical Industry - Debt and Equity Financing Trends, Issues & Trends|

Chemical Industry Financings in 2020 and Outlook (ICIS Chemical Business February 26, 2021)

news2021-05-28T16:06:43+00:00March 1st, 2021|Featured, Our Publications|

Chemical debt and equity financing surged due to the pandemic, but outlook still healthy

Chemical M&A – Yearend Summary and Forecast (ICIS Chemical Business, Feb 12, 2021 issue)

news2021-05-28T16:07:03+00:00February 26th, 2021|Featured, Our Publications|

After slower M&A market in 2020, Young & Partners forecasts a recovery

Press Release: Société de Chimie Industrielle Elects Peter Young as President (December 10, 2020)

news2021-07-01T19:04:05+00:00December 10th, 2020|Our Publications|

Leading Chemicals and Life Science industry association elects new officers for 2021

2020 Chemical Conference Speaker Summary

digitalstudios2021-11-17T17:41:54+00:00November 17th, 2020|Chemical Conferences|

Young & Partners 2020 Chemical Conference: Jim Fitterling & Raj Gupta Fireside Chat

news2021-06-15T22:13:07+00:00November 17th, 2020|Our Broadcasts|

Peter Young moderates fireside chat with Jim Fitterling, CEO of Dow Inc., and Raj Gupta, Chairman of Avantor, Inc. They discuss how their various organizations are adapting to both short-term and long-term change in their respective industries from the CEO and Board perspective.

Young & Partners 2020 Chemical Conference: Keynote Speakers Jim Fitterling & Raj Gupta: Adapting to Change – The CEO and Board Perspective

news2021-07-01T19:47:55+00:00November 17th, 2020|Our Broadcasts|

Jim Fitterling, Chairman and CEO, Dow Chemical Company; Rajiv L. Gupta, Chairman, Aptiv PLC, Former CEO, Rohm & Haas Company, Board Member, DuPont

2020 Life Science Speaker Summary

digitalstudios2021-05-28T15:46:39+00:00October 28th, 2020|Life Science Conferences|

Young & Partners 2020 Pharmaceutical Executive Summit: Peter Marks Keynote Speech: Perspective on the Development of Vaccines and Gene Therapies

news2021-06-15T22:12:08+00:00October 28th, 2020|Our Broadcasts|

Welcoming Comments by Peter Young, CEO of Young & Partners and the Keynote Speech of Peter Marks of the FDA.

Young & Partners 2020 Pharmaceutical Executive Summit: Peter Marks Fireside Chat: The Impact of the Pandemic

news2021-07-01T19:48:25+00:00October 28th, 2020|Our Broadcasts|

Fireside Chat featuring Peter Marks of the FDA, interviewed by Dr. Stephen Spielberg, Senior Advisor, Young & Partners

Pharma Exec – Taking Pharma’s Pulse in a Tough 2020 (Young & Partners article Sept 2020)

news2021-07-01T19:04:52+00:00September 10th, 2020|Our Publications|

Assessing COVID-19’s wide and varied impact on pharma and biotech business in the first half of the year, and how it shapes market prospects ahead

Debt and Equity Markets Buoyant (ICIS Chemical Business September 4 2020)

news2021-12-03T20:09:58+00:00September 4th, 2020|Our Publications|

Data shows a strong debt market and solid equity issuance, but IPOs all Asian